Letters
Statins and The BMJ
The debate on statins must stay in the public domain
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5383 (Published 03 September 2014) Cite this as: BMJ 2014;349:g5383
- Jerome Burne, journalist1
- 1London W9 1EL, UK
- jerome{at}burne.myzen.co.uk
As a medical journalist, I’m concerned about the recommendation of the independent panel considering the retraction of two BMJ papers that the ongoing statin debate “be conducted primarily in medical journals rather than in the lay media.”1
How could this be enforced? Could I be fined or imprisoned for reporting dissenting data? And what about The BMJ’s support for transparency? Debate behind closed …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.